Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development

Shibin Yu, Bryan Poe, Margaret Schwarz, Sarah A. Elliot, Kurt H. Albertine, Stephen Fenton, Vidu Garg, Anne M. Moon

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The fibroblast growth factor, FGF8, has been shown to be essential for vertebrate cardiovascular, craniofacial, brain and limb development. Here we report that Fgf8 function is required for normal progression through the late fetal stages of lung development that culminate in alveolar formation. Budding, lobation and branching morphogenesis are unaffected in early stage Fgf8 hypomorphic and conditional mutant lungs. Excess proliferation during fetal development disrupts distal airspace formation, mesenchymal and vascular remodeling, and Type I epithelial cell differentiation resulting in postnatal respiratory failure and death. Our findings reveal a previously unknown, critical role for Fgf8 function in fetal lung development and suggest that this factor may also contribute to postnatal alveologenesis. Given the high number of premature infants with alveolar dysgenesis and lung dysplasia, and the accumulating evidence that short-term benefits of available therapies may be outweighed by long-term detrimental effects on postnatal alveologenesis, the therapeutic implications of identifying a factor or pathway that can be targeted to stimulate normal alveolar development are profound.

Original languageEnglish (US)
Pages (from-to)92-108
Number of pages17
JournalDevelopmental Biology
Volume347
Issue number1
DOIs
StatePublished - Nov 1 2010
Externally publishedYes

Fingerprint

Lung
Fetal Development
Fibroblast Growth Factors
Morphogenesis
Premature Infants
Respiratory Insufficiency
Vertebrates
Cell Differentiation
Extremities
Epithelial Cells
Brain
Therapeutics
Vascular Remodeling

Keywords

  • Alveologenesis
  • Differentiation
  • FGF
  • Lung development
  • Mouse model
  • Proliferation
  • Pulmonary vascular development
  • Type I alveolar cell
  • Type II alveolar cell

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology
  • Molecular Biology

Cite this

Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development. / Yu, Shibin; Poe, Bryan; Schwarz, Margaret; Elliot, Sarah A.; Albertine, Kurt H.; Fenton, Stephen; Garg, Vidu; Moon, Anne M.

In: Developmental Biology, Vol. 347, No. 1, 01.11.2010, p. 92-108.

Research output: Contribution to journalArticle

Yu, Shibin ; Poe, Bryan ; Schwarz, Margaret ; Elliot, Sarah A. ; Albertine, Kurt H. ; Fenton, Stephen ; Garg, Vidu ; Moon, Anne M. / Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development. In: Developmental Biology. 2010 ; Vol. 347, No. 1. pp. 92-108.
@article{982e4f49784b4b599c8e0a41c7662f24,
title = "Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development",
abstract = "The fibroblast growth factor, FGF8, has been shown to be essential for vertebrate cardiovascular, craniofacial, brain and limb development. Here we report that Fgf8 function is required for normal progression through the late fetal stages of lung development that culminate in alveolar formation. Budding, lobation and branching morphogenesis are unaffected in early stage Fgf8 hypomorphic and conditional mutant lungs. Excess proliferation during fetal development disrupts distal airspace formation, mesenchymal and vascular remodeling, and Type I epithelial cell differentiation resulting in postnatal respiratory failure and death. Our findings reveal a previously unknown, critical role for Fgf8 function in fetal lung development and suggest that this factor may also contribute to postnatal alveologenesis. Given the high number of premature infants with alveolar dysgenesis and lung dysplasia, and the accumulating evidence that short-term benefits of available therapies may be outweighed by long-term detrimental effects on postnatal alveologenesis, the therapeutic implications of identifying a factor or pathway that can be targeted to stimulate normal alveolar development are profound.",
keywords = "Alveologenesis, Differentiation, FGF, Lung development, Mouse model, Proliferation, Pulmonary vascular development, Type I alveolar cell, Type II alveolar cell",
author = "Shibin Yu and Bryan Poe and Margaret Schwarz and Elliot, {Sarah A.} and Albertine, {Kurt H.} and Stephen Fenton and Vidu Garg and Moon, {Anne M.}",
year = "2010",
month = "11",
day = "1",
doi = "10.1016/j.ydbio.2010.08.013",
language = "English (US)",
volume = "347",
pages = "92--108",
journal = "Developmental Biology",
issn = "0012-1606",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development

AU - Yu, Shibin

AU - Poe, Bryan

AU - Schwarz, Margaret

AU - Elliot, Sarah A.

AU - Albertine, Kurt H.

AU - Fenton, Stephen

AU - Garg, Vidu

AU - Moon, Anne M.

PY - 2010/11/1

Y1 - 2010/11/1

N2 - The fibroblast growth factor, FGF8, has been shown to be essential for vertebrate cardiovascular, craniofacial, brain and limb development. Here we report that Fgf8 function is required for normal progression through the late fetal stages of lung development that culminate in alveolar formation. Budding, lobation and branching morphogenesis are unaffected in early stage Fgf8 hypomorphic and conditional mutant lungs. Excess proliferation during fetal development disrupts distal airspace formation, mesenchymal and vascular remodeling, and Type I epithelial cell differentiation resulting in postnatal respiratory failure and death. Our findings reveal a previously unknown, critical role for Fgf8 function in fetal lung development and suggest that this factor may also contribute to postnatal alveologenesis. Given the high number of premature infants with alveolar dysgenesis and lung dysplasia, and the accumulating evidence that short-term benefits of available therapies may be outweighed by long-term detrimental effects on postnatal alveologenesis, the therapeutic implications of identifying a factor or pathway that can be targeted to stimulate normal alveolar development are profound.

AB - The fibroblast growth factor, FGF8, has been shown to be essential for vertebrate cardiovascular, craniofacial, brain and limb development. Here we report that Fgf8 function is required for normal progression through the late fetal stages of lung development that culminate in alveolar formation. Budding, lobation and branching morphogenesis are unaffected in early stage Fgf8 hypomorphic and conditional mutant lungs. Excess proliferation during fetal development disrupts distal airspace formation, mesenchymal and vascular remodeling, and Type I epithelial cell differentiation resulting in postnatal respiratory failure and death. Our findings reveal a previously unknown, critical role for Fgf8 function in fetal lung development and suggest that this factor may also contribute to postnatal alveologenesis. Given the high number of premature infants with alveolar dysgenesis and lung dysplasia, and the accumulating evidence that short-term benefits of available therapies may be outweighed by long-term detrimental effects on postnatal alveologenesis, the therapeutic implications of identifying a factor or pathway that can be targeted to stimulate normal alveolar development are profound.

KW - Alveologenesis

KW - Differentiation

KW - FGF

KW - Lung development

KW - Mouse model

KW - Proliferation

KW - Pulmonary vascular development

KW - Type I alveolar cell

KW - Type II alveolar cell

UR - http://www.scopus.com/inward/record.url?scp=77957320930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957320930&partnerID=8YFLogxK

U2 - 10.1016/j.ydbio.2010.08.013

DO - 10.1016/j.ydbio.2010.08.013

M3 - Article

VL - 347

SP - 92

EP - 108

JO - Developmental Biology

JF - Developmental Biology

SN - 0012-1606

IS - 1

ER -